Literature DB >> 24973950

The impact of atrial fibrillation and its treatment on dementia.

Arun Kanmanthareddy1, Ajay Vallakati, Arun Sridhar, Madhu Reddy, Hari Priya Sanjani, Jayasree Pillarisetti, Donita Atkins, Sudharani Bommana, Misty Jaeger, Loren Berenbom, Dhanunjaya Lakkireddy.   

Abstract

Atrial fibrillation (AF) is a very common tachyarrhythmia and is becoming increasingly prevalent, while dementia is a neurological condition manifested as loss of memory and cognitive ability. Both these conditions share several common risk factors. It is becoming increasingly evident that AF increases the risk of dementia. There are several pathophysiological mechanisms by which AF can cause dementia. AF increases the stroke risk and strokes are strongly associated with dementia. Besides stroke, altered cerebral blood flow in AF and cerebral microbleeds from anticoagulation may enhance the risk of dementia. Maintaining sinus rhythm may therefore decrease this risk. Catheter ablation is emerging as an effective alternative to maintain patients in sinus rhythm. This procedure has also shown promise in decreasing the risk of all types of dementia. Besides maintaining sinus rhythm and oral anticoagulation, aggressive risk factor modification may reduce the likelihood or delay the onset of dementia.

Entities:  

Mesh:

Year:  2014        PMID: 24973950     DOI: 10.1007/s11886-014-0519-y

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  71 in total

1.  Atrial fibrillation and dementia in a population-based study. The Rotterdam Study.

Authors:  A Ott; M M Breteler; M C de Bruyne; F van Harskamp; D E Grobbee; A Hofman
Journal:  Stroke       Date:  1997-02       Impact factor: 7.914

2.  Global prevalence of dementia: a Delphi consensus study.

Authors:  Cleusa P Ferri; Martin Prince; Carol Brayne; Henry Brodaty; Laura Fratiglioni; Mary Ganguli; Kathleen Hall; Kazuo Hasegawa; Hugh Hendrie; Yueqin Huang; Anthony Jorm; Colin Mathers; Paulo R Menezes; Elizabeth Rimmer; Marcia Scazufca
Journal:  Lancet       Date:  2005-12-17       Impact factor: 79.321

3.  Cerebral computed tomography in paroxysmal atrial fibrillation.

Authors:  P Petersen; F Pedersen; A Johnsen; E B Madsen; B Brun; G Boysen; J Godtfredsen
Journal:  Acta Neurol Scand       Date:  1989-06       Impact factor: 3.209

4.  Cerebral blood flow before and after cardioversion of atrial fibrillation.

Authors:  P Petersen; J Kastrup; R Videbaek; G Boysen
Journal:  J Cereb Blood Flow Metab       Date:  1989-06       Impact factor: 6.200

5.  Silent brain infarcts and the risk of dementia and cognitive decline.

Authors:  Sarah E Vermeer; Niels D Prins; Tom den Heijer; Albert Hofman; Peter J Koudstaal; Monique M B Breteler
Journal:  N Engl J Med       Date:  2003-03-27       Impact factor: 91.245

6.  MR detection of microhemorrhages in neurologically healthy adults.

Authors:  Y Tsushima; Y Tanizaki; J Aoki; K Endo
Journal:  Neuroradiology       Date:  2002-01       Impact factor: 2.804

7.  Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds.

Authors:  F Fazekas; R Kleinert; G Roob; G Kleinert; P Kapeller; R Schmidt; H P Hartung
Journal:  AJNR Am J Neuroradiol       Date:  1999-04       Impact factor: 3.825

8.  Nonembolic, hemodynamic blood flow disturbances in the middle cerebral arteries in patients with paroxysmal atrial fibrillation without significant carotid stenosis.

Authors:  Agata Porebska; Przemyslaw Nowacki; Krzysztof Safranow; Hanna Drechsler
Journal:  Clin Neurol Neurosurg       Date:  2007-07-20       Impact factor: 1.876

9.  Alzheimer disease in the US population: prevalence estimates using the 2000 census.

Authors:  Liesi E Hebert; Paul A Scherr; Julia L Bienias; David A Bennett; Denis A Evans
Journal:  Arch Neurol       Date:  2003-08

10.  Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study.

Authors:  M W Vernooij; A van der Lugt; M A Ikram; P A Wielopolski; W J Niessen; A Hofman; G P Krestin; M M B Breteler
Journal:  Neurology       Date:  2008-04-01       Impact factor: 9.910

View more
  5 in total

Review 1.  Emerging risk biomarkers in cardiovascular diseases and disorders.

Authors:  Ravi Kant Upadhyay
Journal:  J Lipids       Date:  2015-04-08

2.  Alteration of cerebrovascular haemodynamic patterns due to atrial fibrillation: an in silico investigation.

Authors:  S Scarsoglio; A Saglietto; M Anselmino; F Gaita; L Ridolfi
Journal:  J R Soc Interface       Date:  2017-04       Impact factor: 4.118

Review 3.  Impact of catheter ablation versus medical therapy on cognitive function in atrial fibrillation: a systematic review.

Authors:  Neil Bodagh; Reuben Yap; Irum Kotadia; Iain Sim; Ajay Bhalla; Peter Somerville; Mark O'Neill; Steven E Williams
Journal:  J Interv Card Electrophysiol       Date:  2022-04-05       Impact factor: 1.759

4.  Transient cerebral hypoperfusion and hypertensive events during atrial fibrillation: a plausible mechanism for cognitive impairment.

Authors:  Matteo Anselmino; Stefania Scarsoglio; Andrea Saglietto; Fiorenzo Gaita; Luca Ridolfi
Journal:  Sci Rep       Date:  2016-06-23       Impact factor: 4.379

5.  Dementia and Traffic Accidents: A Danish Register-Based Cohort Study.

Authors:  Jindong Ding Petersen; Volkert Siersma; Connie Thurøe Nielsen; Mikkel Vass; Frans Boch Waldorff
Journal:  JMIR Res Protoc       Date:  2016-09-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.